POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887 | -26.4% | 132,990 | 0.0% | 0.09% | -22.4% |
| Q2 2023 | $1,205 | +15.5% | 132,990 | -7.3% | 0.12% | +5.5% |
| Q1 2023 | $1,043 | -0.3% | 143,490 | 0.0% | 0.11% | -9.1% |
| Q4 2022 | $1,046 | -99.9% | 143,490 | 0.0% | 0.12% | -9.0% |
| Q3 2022 | $1,109,000 | -9.2% | 143,490 | -20.0% | 0.13% | +0.8% |
| Q2 2022 | $1,221,000 | -14.6% | 179,362 | 0.0% | 0.13% | +4.8% |
| Q1 2022 | $1,430,000 | +42.4% | 179,362 | 0.0% | 0.13% | +57.5% |
| Q4 2021 | $1,004,000 | – | 179,362 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |